Sign Up to like & get
recommendations!
1
Published in 2022 at "ChemMedChem"
DOI: 10.1002/cmdc.202200043
Abstract: The sulfotransferase (SULT) 2B1b, which catalyzes the sulfonation of 3β‐hydroxysteroids, has been identified as a potential target for prostate cancer treatment. However, a major limitation for SULT2B1b‐targeted drug discovery is the lack of robust assays…
read more here.
Keywords:
label free;
sult2b1b;
mass spectrometry;
desorption electrospray ... See more keywords